drug formulation News
-
Versatile formulation of active ingredients, adapted to poorly water-soluble or rapidly metabolised drugs, allowing their solubilisation, protection and targeted delivery
Interested in Adjuvatis’ drug formulation technology but want to learn more? Meet us at the Forum de la Recherche en Cancérologie organized by the Canceropole Rhone-Alpes CLARA, in April. Charlotte Primard, our CEO, will pitch Versatile formulation of active ingredients, adapted to poorly water-soluble or rapidly metabolised drugs, allowing their solubilisation, protection and ...
By Adjuvatis
-
Showcase
ARAI-2PAM Barda Procurement Award
Broomfield, Colorado, 10/3/2022. Aktiv Pharma Group (Aktiv) today announced a procurement contract award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). Under this contract (number 75A50122C00082), awarded under the 2004 Project ...
-
CD Formulation: One-Stop Pharmaceutical Formulation Solution Makes Drug Development Faster, Easier and More Cost-Effective
Appropriate drug formulation is a prerequisite for successful drug development. CD Formulation, a highly specialized CRO service provider, recently announced its capability of offering one-stop pharmaceutical formulation solutions that can make drug development faster, easier, and more cost-effective. Drug formulation, or pharmaceutical formulation, is a universal challenge faced by biotech ...
-
CD Formulation Launches API Chemical Modification Services to Address Drug Solubility, Bioavailability, and Dissolution Rate Issues
Having abundant expertise in drug formulation and pharmaceutical preparation, the New York-based CRO company CD Formulation recently announces that it is now capable of conducting a wide range of API chemical modification services, including pH modification drug molecular service, drug salt formation service, drug pegylation service, and different groups of precursor drug design service, to help ...
-
CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients
Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium ...
-
CD Formulation Stresses the Importance of Increased Bioavailability Excipients in Drug Formulation
Specializing in drug formulation, the highly specialized CRO service provider CD Formulation has accumulated abundant experience in the custom synthesis of increased bioavailability excipients. To meet the requirements of different drug research projects, excipients can be tailor-made in varied specifications and volumes. Recently, adding increased bioavailability excipients in drug formulations ...
-
CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients in Drug Discovery
As a New York-based CRO company, CD Formulation has keenly observed that the demand for tailored pharmaceutical excipients is on the rise, especially over the past decade, as each formulation project may need unique excipients. In response to such a market trend, the management of CD Formulation earlier this month announces to offer customized synthesis for lipid excipients, which are used in ...
-
CD Formulation Unveils Hygroscopicity Evaluation for Drug Formulation
For solid dosage formulation chemists, it is usually a formidable task to crystalize the moisture adsorption conditions for pharmaceutical substances. To help researchers better solve this problem, CD Formulation avails its position in the industry as a contract service provider and announces to offer hygroscopicity evaluation for custom pharmaceutical formulation projects. Hygroscopicity is a ...
-
Revolutionize Your Drug Preformulation Workflows with the Precellys Evolution Homogenizer!
In a recent study in the European Journal of Pharmaceutics and Biopharmaceutics, Jochem Alsenz and Elisabeth Haenel present Precellys® Evolution homogenizer with Cryolys Evolution, a patent cooling system, as a versatile tool for improving preformulation processes in drug development. The study highlights the various uses of Precellys® Evolution homogenizer with Cryolys Evolution, ...
-
Showcase
Aktiv Pharma Group Receives Grant Funding to Develop Tranexamic Acid Autoinjector
Broomfield Colorado 6/25/2022. Aktiv Pharma Group (Aktiv) announced today a grant award from the U.S. Department of Defense (DOD) Defense Health Agency (DHA) Joint Program Committee 6/Combat Casualty Care Research Program (JPC-6/CCCRP) [1] for the continued development of a tranexamic acid (TXA) autoinjector, targeting proposed indications related to prehospital treatment of severe bleeding. ...
-
CD Formulation: A Supplier of Binder Excipients for Pharmaceutical Preparation
Excipients play a remarkable role in the process of drug formulation. Binder excipients are used to improve the disintegration, bulkiness, bioavailability and dissolution rate of the drug. To make binder excipients more accessible for researchers, CD Formulation recently announced a comprehensive range of binder excipients that can be used in pharmaceutical research. By definition, the function ...
-
CD Formulation Launches GalNAc Coupling Modification Services for the Development of Drug Delivery Systems
Over the past decade, the CD Formulation’s expert team has made tireless efforts in the research and development of drug delivery systems, trying to improve the pharmacokinetics and pharmacodynamics of drugs. In order to achieve the optimal therapeutic effect, the required dose must be delivered at the target site at the appropriate time and rate. “We have developed various drug ...
-
CD Formulation Releases Solubility Analysis to Assist Drug R&D Projects
Solubility measurement is a key element for a preliminary understanding of the pharmacodynamic properties of the drug. On August 30, 2021, CD Formulation, a leading CRO service provider in the industry, announces the release of drug solubility analysis, which is an indispensable step in drug development and formulation to ensure efficacy and quality of drugs. Drug substances have to be dissolved ...
-
CD Formulation Offers Insights, Strategies, and Practical Suggestions on Pre-formulation Studies for Pharmaceuticals
In a recent statement, the US-based CRO company CD Formulation re-demonstrated its competence in drug development and announced that it now offers industry-leading insights, strategies, and practical suggestions on pre-formulation studies for drug developers worldwide. The past decade has witnessed a boom of new chemical entities development in the hope of bringing more therapies to diseases hard ...
-
EsoCap announces issue of U.S. patent for its smart application technology in the upper gastrointestinal tract
EsoCap AG has announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,744,095 on August 18, 2020. The patent is directed at the smart application technology enabling specific sitedirected treatment of several diseases of the esophagus. “Issue of the U.S. patent is a major milestone confirming the novelty of EsoCap’s proprietary ...
By EsoCap AG
-
CD Formulation Provides Moisture Content Determination for Drug Formulation and Analysis
Moisture testing is viewed as one of the most fundamental quality parameters to ensure drug stability. Earlier this month, CD Formulation announces the release of moisture content determination service of active pharmaceutical ingredients (APIs) and inactive ingredients for researchers who are engaged with drug development and formulation. Moisture determination is an important aspect of many ...
-
CD Formulation Announces to Optimize Stability Analysis for Drug Pre-formulation Research
Recognized as a CRO for pharmaceutical formulation, CD Formulation recently announces to have optimized its stability analysis service, providing solid-state stability analysis, solution-state stability analysis, APIs-excipients compatibility analysis for researchers devoted to drug formulation research. Current Good Manufacturing Practice for Finished Pharmaceuticals (CGMPs) has already ...
-
CD Formulation Enhances Its Food Ingredients Lineup with Upgraded Acidity Regulators, Anticaking Agents, and Coating Agents
CD Formulation, a leading food ingredients supplier, recently announced the launch of its upgraded lineup of acidity regulators, anticaking agents, and coating agents. These high-quality products are designed to improve the texture, taste, and appearance of various food products. Acidity RegulatorsCD Formulation's acidity regulators are designed to enhance the flavor and quality of food ...
-
CD Formulation Strengthens Its Role as a CRO Company for Pharmaceuticals
Combining robust expertise and years of experience, the US-based company CD Formulation further strengthens its role as a contract service provider for pharmaceutical companies in a recent statement. Though the service portfolio of CD Formulation is far-ranged and nearly covers the whole process of drug formulation, encompassing pre-formulation, formulation, drug analysis, solubility improvement ...
-
Alfa Chemistry Leads the Way to Unleash Power of Computational Solutions in Solid State Chemistry for Pharmaceutical Research
In the ever-evolving field of pharmaceutical research, the hunt for effective drugs often rests on the ability to understand and manipulate the solid-state properties of compounds. Alfa Chemistry, a leading provider of research and development solutions, is taking the lead in harnessing the power of computational solutions in solid state chemistry to facilitate pharmaceutical research. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you